Facility
Taro Pharmaceutical Brampton Manufacturing
Primary finished dose manufacturing site for Taro's US topical dermatology portfolio; produces corticosteroid creams, ointments, gels; FDA-registered and inspected; ~300-400 ANDA products in US market manufactured here; Canadian site allows tariff-free US entry under USMCA
1
Inputs produced
1
Goods downstream
0
Incidents on record
0
Stories
What's produced here
1 input from this facility
Tap an input to see every good that depends on it, every country that produces it, and every other company in the supply chain.